株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界におけるポイントオブケア診断/検査市場の規模、シェア、動向分析:製品別(グルコース、血液ガス/電解質、癌マーカー)、エンドユース別(クリニック、病院)、セグメント予測

Point of Care Diagnostics/Testing Market Size, Share & Trends Analysis Report by Product (Glucose, Blood Gas/Electrolytes, Cancer Marker), By End Use (Clinic, Hospital), And Segment Forecasts, 2019 - 2025

発行 Grand View Research, Inc. 商品コード 608208
出版日 ページ情報 英文 252 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.24円で換算しております。
Back to Top
世界におけるポイントオブケア診断/検査市場の規模、シェア、動向分析:製品別(グルコース、血液ガス/電解質、癌マーカー)、エンドユース別(クリニック、病院)、セグメント予測 Point of Care Diagnostics/Testing Market Size, Share & Trends Analysis Report by Product (Glucose, Blood Gas/Electrolytes, Cancer Marker), By End Use (Clinic, Hospital), And Segment Forecasts, 2019 - 2025
出版日: 2019年03月18日 ページ情報: 英文 252 Pages
概要

当レポートでは、世界のポイントオブケア診断/検査市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法と調査範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場直線見通し
  • 浸透度と成長見通しマッピング
  • 製品ポジショニング分析
  • 価格・コスト・利幅分析
  • ユーザー展望分析
  • 主要エンドユーザーリスト
  • 技術概要
  • 法規制の枠組み
  • 市場動向
    • 市場促進因子分析
    • 市場阻害因子分析
    • 市場の課題
  • 市場分析ツール

第4章 競合分析

  • 近年の発展と影響分析
  • 企業/競合分類
  • ベンダー環境
  • 公的企業
  • 民間企業

第5章 製品別予測と動向分析

  • 定義と範囲
  • 市場シェア分析
  • 製品動向分析
  • 世界市場
  • 市場規模と予測、動向分析
    • 血糖検査
    • Hb1Ac検査
    • 凝固検査
    • 不妊検査
    • 癌マーカー
    • 感染症検査
    • プライマリーケアシステム
    • 血液学検査
    • 分散臨床化学
    • 血液ガス/電解質検査
    • 外来化学
    • 尿検査
    • 薬物乱用検査
    • 甲状腺刺激ホルモン
    • 便検査
    • 脂質検査
    • 癌マーカー検査
  • 製品市場

第6章 エンドユース別予測と動向分析

  • 定義と範囲
  • 市場シェア分析
  • 動向分析
  • 世界市場
  • 市場規模と予測、動向分析
    • クリニック
    • 病院
    • 自宅
    • 介護施設
    • 試験所
    • その他

第7章 地域別予測と動向分析

  • 市場シェア
  • 地域別市場シェアと主要企業
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合環境

  • 戦略枠組み
  • 市場参入分類
  • 企業プロファイル
図表

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 Market driver relevance analysis (Current & future impact)
  • TABLE 3 Market restraint relevance analysis (Current & future impact)
  • TABLE 4 North America point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 5 North America point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 6 U.S. point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 7 U.S. point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 8 Canada point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 9 Canada point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 10 Europe point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 11 Europe point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 12 Germany point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 13 Germany point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 14 U.K. point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 15 U.K. point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 16 Spain point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 17 Spain point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 18 Italy point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 19 Italy point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 20 France point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 21 France point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 22 Asia Pacific point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 23 Asia Pacific point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 24 Japan point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 25 Japan point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 26 China point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 27 China point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 28 India point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 29 India point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 30 Korea point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 31 Korea point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 32 Australia point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 33 Australia point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 34 Singapore point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 35 Singapore point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 36 Latin America point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 37 Latin America point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 38 Brazil point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 39 Brazil point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 40 Mexico point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 41 Mexico point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 42 Argentina point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 43 Argentina point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 44 Chile point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 45 Chile point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 46 MEA point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 47 MEA point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 48 South Africa point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 49 South Africa point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 50 Kenya point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 51 Kenya point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 52 Nigeria point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 53 Nigeria point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 54 Saudi Arabia point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 55 Saudi Arabia point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 56 Zimbabwe point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 57 Zimbabwe point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 58 UAE point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 59 UAE point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
  • TABLE 60 Qatar point of care diagnostics/testing market estimates and forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 61 Qatar point of care diagnostics/testing market estimates and forecasts, by end use, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Shift in POC molecular diagnostic trends
  • FIG. 12 Global percentage of population, by age group, 2000 and 2050
  • FIG. 13 Population over the age of 65 years, by region, 2010 and 2050
  • FIG. 14 Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
  • FIG. 15 Current and projected prevalence of diabetes, by geography, 2013 & 2035 (% increase)
  • FIG. 16 Market restraint relevance analysis (Current & future impact)
  • FIG. 17 Penetration & growth prospect mapping for products, 2018
  • FIG. 18 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 19 Porter's Five Forces Analysis
  • FIG. 20 Competitive landscape POC diagnostics - Major market participants
  • FIG. 21 POC diagnostics - product segments positioning, 2018
  • FIG. 22 Marketing channels
  • FIG. 23 Roche distribution presence
  • FIG. 24 Instrumentation Laboratory (Werfen Group) distribution presence
  • FIG. 25 Abbott Laboratories distribution network coverage
  • FIG. 26 Alere distribution presence
  • FIG. 27 Siemens Healthcare distribution presence
  • FIG. 28 Danaher distribution presence (Radiometer and Beckman Coulter)
  • FIG. 29 Point-of-care diagnostics market product outlook key takeaways
  • FIG. 30 Point-of-care diagnostics market: Product movement analysis
  • FIG. 31 Global POC glucose testingmarket, 2014 - 2025 (USD Million)
  • FIG. 32 Global POC Hb1Ac testing market, 2014 - 2025 (USD Million)
  • FIG. 33 Global POC coagulation testing market, 2014 - 2025 (USD Million)
  • FIG. 34 Global POC fertility market, 2014 - 2025 (USD Million)
  • FIG. 35 Global POC cardiac markers market, 2014 - 2025 (USD Million)
  • FIG. 36 Global POC infectious diseases testingmarket, 2014 - 2025 (USD Million)
  • FIG. 37 Global HIV POC testing market, 2014 - 2025 (USD Million)
  • FIG. 38 Global Clostridium difficile POC testing market, 2014 - 2025 (USD Million)
  • FIG. 39 Global HBV POC testing market, 2014 - 2025 (USD Million)
  • FIG. 40 Global pneumonia or streptococcus associated infectionsPOC testing market, 2014 - 2025 (USD Million)
  • FIG. 41 Global respiratory syncytial virus (RSV) POC testing market, 2014 - 2025 (USD Million)
  • FIG. 42 Global HPV POC testing market, 2014 - 2025 (USD Million)
  • FIG. 43 Global influenza/flu POC testing market, 2014 - 2025 (USD Million)
  • FIG. 44 Global HCVPOC testing market, 2014 - 2025 (USD Million)
  • FIG. 45 Global MRSA POC testing market, 2014 - 2025 (USD Million)
  • FIG. 46 Global TB and drug-resistant TBPOC testing market, 2014 - 2025 (USD Million)
  • FIG. 47 Global HSV POC testing market, 2014 - 2025 (USD Million)
  • FIG. 48 Global other infectious diseases POC testing market, 2014 - 2025 (USD Million)
  • FIG. 49 Global primary care systems (includes lipid) POC testing market, 2014 - 2025 (USD Million)
  • FIG. 50 Global hematology testing market, 2014 - 2025 (USD Million)
  • FIG. 51 Global decentralized clinical chemistry POC testing market, 2014 - 2025 (USD Million)
  • FIG. 52 Global feces POC testing market, 2014 - 2025 (USD Million)
  • FIG. 53 Global blood gas/electrolytesPOC testing market, 2014 - 2025 (USD Million)
  • FIG. 54 Global ambulatory chemistryPOC testing market, 2014 - 2025 (USD Million)
  • FIG. 55 Global urinalysis POC testing market, 2014 - 2025 (USD Million)
  • FIG. 56 Global drug abuse POC testing market, 2014 - 2025 (USD Million)
  • FIG. 57 Global thyroid stimulating hormone POC testing market, 2014 - 2025 (USD Million)
  • FIG. 58 Global lipid POC testing market, 2014 - 2025 (USD Million)
  • FIG. 59 Global cancer markers POC testing market, 2014 - 2025 (USD Million)
  • FIG. 60 Point-of-care diagnostics market: End use outlook key takeaways
  • FIG. 61 Global point-of-care diagnostics market: End use movement analysis
  • FIG. 62 Global primary care clinics market, 2014 - 2025 (USD Million)
  • FIG. 63 Global hospitals market, 2014 - 2025 (USD Million)
  • FIG. 64 Global home POC testing market, 2014 - 2025 (USD Million)
  • FIG. 65 Global assisted living healthcare facilities testingmarket, 2014 - 2025 (USD Million)
  • FIG. 66 Global laboratory market, 2014 - 2025 (USD Million)
  • FIG. 67 Regional market place: Key takeaway
  • FIG. 68 Point-of-care diagnosticsregional outlook, 2018 & 2025
  • FIG. 69 North America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 70 U.S. point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 71 Canada point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 72 Europe point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 73 Germany point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 74 France point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 75 U.K. point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 76 Italy point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 78 Spain point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 79 Asia Pacific point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 80 Japan point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 81 China point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 82 India point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 83 Korea point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 84 Australia point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 85 Singapore point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 86 Latin America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 87 Brazil point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 88 Mexico point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 89 Chile point of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 90 Argentina POINT of care diagnostics/testing market, 2014 - 2025 (USD Million)
  • FIG. 91 Middle East & Africa. point-of-care diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 92 South Africa point-of-care diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 93 Saudi Arabia point-of-care diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 94 UAE point-of-care diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 95 Nigeria point-of-care diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 96 Qatar point-of-care diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 97 Kenya point-of-care diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 98 Zimbabwe point-of-care diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 99 Strategy framework
  • FIG. 100 Participant categorization
  • FIG. 101 List of companies
目次
Product Code: 978-1-68038-046-0

The global point of care testing market size is expected to reach USD 22.8 billion by 2025, at a CAGR of 3.3%, according to a new report by Grand View Research, Inc. The ability of Point of Care (POC) tests to render rapid and accurate results to promote patient-centered healthcare at bedside settings as well as in the remote areas results in higher penetration of POC devices and solutions.

Adaptation of automated laboratory systems and highly integrated solutions facilitate the diagnostic workflow, which in turn drives adoption of point of care diagnostic/testing products. Lack of skilled professionals or medical personnel with limited training especially in diagnostics can also easily use these devices.

Rise in R&D activities among key players to introduce novel POC tests and devices for rapid disease detection and monitoring is expected to fuel industrial progression. Recently, in February 2018, Siemens Healthineers received a Food and Drug Administration (FDA) approval for its Total Carbon Dioxide (TCO2) and Blood Urea Nitrogen (BUN) POC tests, thereby enhancing its market presence.

Moreover, high prevalence of chronic disorders and cancer results in large customer base adopting cost-effective and immediate diagnostic tests, propelling the point of care diagnostics/testing market. This is further supplemented by numerous favorable initiatives to promote the employment of POC tests in diagnosis and screening procedures.

Further key findings from the report suggest:

  • Glucose testing held the maximum revenue share in 2018 due to high prevalence of diabetes and introduction of a wide variety of glucose meters by companies
  • Hb1Ac testing segment is also expected to show similar trends owing to high competition among key players while delivering low-cost Hb1Ac tests
  • Detection and analysis of circulating tumor cells during cancer progression is predicted to drive the cancer marker vertical with the fastest penetration rate in the forthcoming years
  • Clinics is estimated to hold the dominant revenue share of the POC diagnostic industry in 2018, due to the employment of a wide range of POC tests
  • Increasing awareness about decentralized tests among patients has resulted in lucrative growth of home-based POC testing
  • U.S. is anticipated to North America owing to the presence of key participants with undergoing significant number of research endeavors in the country
  • Continuous developments in healthcare sector to introduce novel and accurate diagnostic tests exhibit a potential growth of the market in Asia Pacific
  • Major participants in the point of care diagnostics market include F. Hoffmann-La Roche Ltd.; Danaher Corporation; Abbott Laboratories; bioMerieux SA; Instrumentation Laboratory SpA; Nova Biomedical; Trividia Health, Inc.; QIAGEN; Becton Dickinson & Company; Sekisui Diagnostics LLC; Quidel Corporation; and Siemens Healthcare GmbH

Key vendors are: undergoing numerous strategic developments such as product development, acquisitions, partnerships, and agreements to gain greater market share. For instance, in May 2017, Becton, Dickinson and Company collaborated with the FIND to develop point of care based biomarker test for bacterial infections.

Table of Content

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information Analysis
    • 1.3.1 Data analysis models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 Point of Care Diagnostics/Testing Market Outlook, 2014 - 2025
  • 2.2 Point of Care Diagnostics/Testing Market : Segment Outlook, 2014 - 2025
  • 2.3 Point of Care Diagnostics/Testing Market : Competitive Insights

Chapter 3 Point of Care Diagnostics/Testing Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping, 2018
  • 3.3 Product positioning analysis
  • 3.4 Price-cost-margin analysis for point-of-care devices
  • 3.5 User Perspective Analysis
    • 3.5.1. Consumer behavior analysis
    • 3.5.2. Market influencer analysis
  • 3.6 List of Key End-users By Region, By Product, By Country
  • 3.7 Technology Overview
    • 3.7.1. Technology timeline
  • 3.8 Regulatory Framework
    • 3.8.1. Reimbursement framework
    • 3.8.2. Standards & compliances
  • 3.9 Point of Care Diagnostics/Testing Market - Market Dynamics
    • 3.9.1 Market driver analysis
      • 3.9.1.1 Introduction of CLIA waived tests
      • 3.9.1.2 Increasing adoption of POC diagnostics
      • 3.9.1.3 Growing demand for home healthcare and the introduction of advance technology enabled products
      • 3.9.1.4 Growing geriatric population base
      • 3.9.1.5 Growing prevalence of target diseases
    • 3.9.2 Market restraint analysis
      • 3.9.2.1 High procedure costs
      • 3.9.2.2 Presence of ambiguous regulatory framework
    • 3.9.3 Market challenges analysis
      • 3.9.3.1 POC devices pose challenges in maintaining the quality standards
  • 3.10 Point of Care Diagnostics/Testing Market Analysis Tools
    • 3.10.1 Industry Analysis - Porter's
      • 3.11.1.1 Supplier power : Large scale raw material suppliers results in moderate bargaining supplier power
      • 3.11.1.2 Buyer power: High bargaing power of buyer due to increased demand of POC devices
      • 3.11.1.3 Substitution threat: Low substitution threat owing to the lacking replacement for POC procedures
      • 3.11.1.4 New entrants threat: Low new entrant threat owing to large scale investment for POC set up
      • 3.11.1.5 Competitive rivalry: High capitalization due to product launches led to high competitive rivalry
    • 3.10.2 PESTEL analysis
      • 3.10.2.1 Political landscape
      • 3.10.2.2 Environmental landscape
      • 3.10.2.3 Social landscape
      • 3.10.2.4 Technology landscape
      • 3.10.2.5 Legal landscape
    • 3.10.3 Major deals & strategic alliances analysis
      • 3.10.3.1 Joint ventures
      • 3.10.3.2 Mergers & acquisitions
      • 3.10.3.3 Licensing & partnership
      • 3.10.3.4 Technology collaborations
      • 3.10.3.5 Strategic divestments
    • 3.10.4 Market entry strategies
    • 3.10.5 Case studies

Chapter 4 Point of Care Diagnostics/Testing Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Company/Competition Categorization
  • 4.3 Vendor Landscape
    • 4.3.1 Key customers
    • 4.3.2 Key company market share analysis, 2018
  • 4.4 Public Companies
    • 4.4.1 Company market position analysis
    • 4.4.2 Company market share/ranking by region
    • 4.4.3 Competitive dashboard analysis
    • 4.4.4 Market differentiators
    • 4.4.5 Synergy analysis: Major deals & strategic alliances
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
    • 4.5.2 Funding outlook
    • 4.5.3 Regional network map
    • 4.5.4 Company market position analysis
    • 4.5.5 Supplier Ranking

Chapter 5 Point of Care Diagnostics/Testing Market: Product Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Product Market Share Analysis, 2018 & 2025
  • 5.3 Point of Care Diagnostics/Testing Market: Product Movement Analysis, 2018 & 2025
  • 5.4. Global Point of Care Diagnostics/Testing Market, by Product, 2014 to 2025
  • 5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
    • 5.5.1 Glucose testing
      • 5.5.1.1 Glucose testing market, 2014 - 2025 (USD Million)
    • 5.5.2 Hb1Ac testing
      • 5.5.2.1 Hb1Ac testing market, 2014 - 2025 (USD Million)
    • 5.5.3 Coagulation testing
      • 5.5.3.1 Coagulation testing market, 2014 - 2025 (USD Million)
    • 5.5.4 Fertility testing
      • 5.5.4.1 Fertility testing market, 2014 - 2025 (USD Million)
    • 5.5.5 Cardiac markers
      • 5.5.5.1 Cardiac markers market, 2014 - 2025 (USD Million)
    • 5.5.6 Infectious disease testing
      • 5.5.6.1 Infectious disease testing market, 2014 - 2025 (USD Million)
      • 5.5.6.2 HIV POC testing
      • 5.5.6.2.1 Global HIV POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.3 Clostridium Difficile POC testing
      • 5.5.6.3.1 Global Clostridium Difficile POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.4 HBV POC testing
      • 5.5.6.4.1 Global HBV POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.5 Pneumonia or streptococcus associated infections
      • 5.5.6.5.1 Global pneumonia or streptococcus associated infections market, 2014 - 2025 (USD Million)
      • 5.5.6.6 Respiratory Syncytial Virus (RSV) POC testing
      • 5.5.6.6.1 Global Respiratory Syncytial Virus (RSV) POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.7 HPV POC testing
      • 5.5.6.7.1 Global HPV POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.8 Influenza/flu POC testing
      • 5.5.6.8.1 Global influenza/flu POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.9 HCV POC testing
      • 5.5.6.9.1 Global HCV POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.10 MRSA POC testing
      • 5.5.6.10.1 Global MRSA POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.11 TB and drug-resistant TB POC
      • 5.5.6.11.1 Global TB and drug-resistant TB POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.12 HSV POC testing
      • 5.5.6.12.1 Global HSV POC testing market, 2014 - 2025 (USD Million)
      • 5.5.6.13 Other infectious diseases POC testing
      • 5.5.6.13.1 Global other infectious diseases POC testing market, 2014 - 2025 (USD Million)
    • 5.5.7 Primary care systems
      • 5.5.7.1 Primary care systems market, 2014 - 2025 (USD Million)
    • 5.5.8 Hematology testing
      • 5.5.8.1 Hematology testing market, 2014 - 2025 (USD Million)
    • 5.5.9 Decentralized clinical chemistry
      • 5.5.9.1 Decentralized clinical chemistry market, 2014 - 2025 (USD Million)
    • 5.5.10 Blood gas/electrolytes testing
      • 5.5.10.1 Blood gas/electrolytes testing market, 2014 - 2025 (USD Million)
    • 5.5.11 Ambulatory chemistry
      • 5.5.11.1 Ambulatory chemistry market, 2014 - 2025 (USD Million)
    • 5.5.12 Urinalysis
      • 5.5.12.1 Urinanalysis market, 2014 - 2025 (USD Million)
    • 5.5.13 Drug abuse testing
      • 5.5.13.1 Drug abuse testing market, 2014 - 2025 (USD Million)
    • 5.5.14 Thyroid stimulating hormone
      • 5.5.14.1 Thyroid stimulating hormone testing market, 2014 - 2025 (USD Million)
    • 5.5.15 Feces testing
      • 5.5.15.1 Feces testing market, 2014 - 2025 (USD Million)
    • 5.5.16 Lipid testing
      • 5.5.16.1 Lipid testing market, 2014 - 2025 (USD Million)
    • 5.5.17 Cancer marker testing
      • 5.5.17.1 Cancer marker testing market, 2014 - 2025 (USD Million)
  • 5.6 Point of Care Diagnostics/Testing Product Market, by End Use, 2014 to 2025

Chapter 6 Point of Care Diagnostics/Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. End Use Market Share Analysis, 2018 & 2025
  • 6.3 Point of Care Diagnostics/Testing Market: End Use Movement Analysis, 2018 & 2025
  • 6.4. Global Point of Care Diagnostics/Testing Market, by End Use, 2014 to 2025
  • 6.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
    • 6.5.1 Clinics
      • 6.5.1.1 Clinics market, 2014 - 2025 (USD Million)
      • 6.5.1.2 Pharmacy & retail clinics
      • 6.5.1.2.1 Global pharmacy & retail clinics market, 2014 - 2025 (USD Million)
      • 6.5.1.3 Phsician office
      • 6.5.1.3.1 Global phsician office market, 2014 - 2025 (USD Million)
      • 6.5.1.4 Urgent care clinics
      • 6.5.1.4.1 Global urgent care clinics market, 2014 - 2025 (USD Million)
      • 6.5.1.5 Non-practice clinics
      • 6.5.1.5.1 Global non-practice clinics market, 2014 - 2025 (USD Million)
    • 6.5.2 Hospitals
      • 6.5.2.1 Hospitals market, 2014 - 2025 (USD Million)
    • 6.5.3 Home
      • 6.5.3.1 Home market, 2014 - 2025 (USD Million)
    • 6.5.4 Assisted Living Healthcare Facilities
      • 6.5.4.1 Assisted living healthcare facilities market, 2014 - 2025 (USD Million)
    • 6.5.5 Laboratories
      • 6.5.5.1 Laboratories market, 2014 - 2025 (USD Million)
    • 6.5.6 Others
      • 6.5.6.1 Other end use market, 2014 - 2025 (USD Million)

Chapter 7 Point of Care Diagnostics/Testing Market: Regional Estimates & Trend Analysis, by Product, & End Use

  • 7.1 Point of Care Diagnostics/Testing Market Share by Region, 2018 & 2025
  • 7.2 Regional Market Share and Leading Players, 2018
    • 7.2.1 North America
    • 7.2.2 Europe
    • 7.2.3 Asia Pacific
    • 7.2.4 Latin America
    • 7.2.5 Middle East & Africa
  • 7.3 North America
    • 7.3.1 North America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 U.S. point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.3.2.2 U.S. point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.3.3 Canada.
      • 7.3.3.1 Canada point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.3.3.2 Canada point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
  • 7.4 Europe
    • 7.4.1 Europe point of care diagnostics/testing market, 2014 - 2025 (USD Million)
    • 7.4.2 Germany
      • 7.4.2.1 Germany point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.4.2.2 Germany point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.4.3 France
      • 7.4.3.1 France point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.4.3.2 France point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.4.4 Italy
      • 7.4.4.1 Italy point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.4.4.2 Italy point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.4.5 Spain
      • 7.4.5.1 Spain point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.4.5.2 Spain point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.4.6 U.K.
      • 7.4.6.1 U.K. point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.4.6.2 U.K. point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.4.7 Russia
      • 7.4.7.1 Russia point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.4.7.2 Russia point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific point of care diagnostics/testing market, 2014 - 2025 (USD Million)
    • 7.5.2 Japan
      • 7.5.2.1 Japan point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.5.2.2 Japan point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.5.3 China
      • 7.5.3.1 China point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.5.3.2 China point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.5.4 India
      • 7.5.4.1 India point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.5.4.2 India point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.5.5 Australia
      • 7.5.5.1 Australia point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.5.5.2 Australia point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.5.6 Korea
      • 7.5.6.1 Korea point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.5.6.2 Korea point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.5.7 Singapore
      • 7.5.7.1 Singapore point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.5.7.2 Singapore point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
  • 7.6 Latin America
    • 7.6.1 Latin America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Brazil point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.6.2.2 Brazil point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.6.3 Mexico
      • 7.6.3.1 Mexico point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.6.3.2 Mexico point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.6.4 Argentina
      • 7.6.4.1 Argentina point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.6.4.2 Argentina point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.6.5 Chile
      • 7.6.5.1 Chile point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.6.5.2 Chile point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
  • 7.7 Middle East & Africa
    • 7.7.1 Middle East & Africa point of care diagnostics/testing market, 2014 - 2025 (USD Million)
    • 7.7.2 South Africa.
      • 7.7.2.1 South Africa point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.7.2.2 South Africa point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.7.3 Kenya
      • 7.7.3.1 Kenya point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.7.3.2 Kenya point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.7.4 Nigeria
      • 7.7.4.1 Nigeria point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.7.4.2 Nigeria point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.7.5 Saudi Arabia
      • 7.7.5.1 Saudi Arabia point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.7.5.2 Saudi Arabia point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.7.6 Zimbabwe
      • 7.7.6.1 Zimbabwe point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.7.6.2 Zimbabwe point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.7.7 UAE
      • 7.7.7.1 UAE point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.7.7.2 UAE point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
    • 7.7.8 Qatar
      • 7.7.8.1 Qatar point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
      • 7.7.8.2 Qatar point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Strategy framework
  • 8.2 Market participation categorization
  • 8.3 Company Profiles
    • 8.3.1 F. Hoffmann-La Roche Ltd.
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Financial Performance
      • 8.3.1.3 Product Benchmarking
      • 8.3.1.4 Strategic Initiatives
    • 8.3.2 Abbott Laboratories
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Financial Performance
      • 8.3.2.3 Product Benchmarking
      • 8.3.2.4 Strategic Initiatives
    • 8.3.3 Siemens Healthcare GmBH
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Financial Performance
      • 8.3.3.3 Product Benchmarking
      • 8.3.3.4 Strategic Initiatives
    • 8.3.4 Danaher Corporation
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Financial Performance
      • 8.3.4.3 Product Benchmarking
      • 8.3.4.4 Strategic Initiatives
    • 8.3.5 bioMerieux SA
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Financial Performance
      • 8.3.5.3 Product Benchmarking
      • 8.3.5.4 Strategic Initiatives
    • 8.3.6 Abaxis, Inc.
      • 8.3.6.1 Company Overview
      • 8.3.6.2 Financial Performance
      • 8.3.6.3 Product Benchmarking
      • 8.3.6.4 Strategic Initiatives
    • 8.3.7 Becton Dickinson & Company
      • 8.3.7.1 Company Overview
      • 8.3.7.2 Financial Performance
      • 8.3.7.3 Product Benchmarking
      • 8.3.7.4 Strategic Initiatives
    • 8.3.8 Qiagen N.V.
      • 8.3.8.1 Company Overview
      • 8.3.8.2 Financial Performance
      • 8.3.8.3 Product Benchmarking
      • 8.3.8.4 Strategic Initiatives
    • 8.3.9 Spectral Diagnostics
      • 8.3.9.1 Company Overview
      • 8.3.9.2 Financial Performance
      • 8.3.9.3 Product Benchmarking
      • 8.3.9.4 Strategic Initiatives
    • 8.3.10 Instrumentation Laboratory SpA
      • 8.3.10.1 Company Overview
      • 8.3.10.2 Financial Performance
      • 8.3.10.3 Product Benchmarking
      • 8.3.10.4 Strategic Initiatives
    • 8.3.11 Johnson and Johnson
      • 8.3.11.1 Company Overview
      • 8.3.11.2 Financial Performance
      • 8.3.11.3 Product Benchmarking
      • 8.3.11.4 Strategic Initiatives
    • 8.3.12 Nova Biomedical
      • 8.3.12.1 Company Overview
      • 8.3.12.2 Financial Performance
      • 8.3.12.3 Product Benchmarking
      • 8.3.12.4 Strategic Initiatives
    • 8.3.13 Nipro Diagnostics Inc
      • 8.3.13.1 Company Overview
      • 8.3.13.2 Financial Performance
      • 8.3.13.3 Product Benchmarking
      • 8.3.13.4 Strategic Initiatives
    • 8.3.14 HemoCue AB
      • 8.3.14.1 Company Overview
      • 8.3.14.2 Financial Performance
      • 8.3.14.3 Product Benchmarking
      • 8.3.14.4 Strategic Initiatives
    • 8.3.15 International Technidyne Corporation (ITC)
      • 8.3.15.1 Company Overview
      • 8.3.15.2 Financial Performance
      • 8.3.15.3 Product Benchmarking
      • 8.3.15.4 Strategic Initiatives
    • 8.3.16 Quidel Corporation
      • 8.3.16.1 Company Overview
      • 8.3.16.2 Financial Performance
      • 8.3.16.3 Product Benchmarking
      • 8.3.16.4 Strategic Initiatives
    • 8.3.17 Trinity Biotech PLC
      • 8.3.17.1 Company Overview
      • 8.3.17.2 Financial Performance
      • 8.3.17.3 Product Benchmarking
      • 8.3.17.4 Strategic Initiatives
    • 8.3.18 Sekisui Diagnostics LLC
      • 8.3.18.1 Company Overview
      • 8.3.18.2 Financial Performance
      • 8.3.18.3 Product Benchmarking
      • 8.3.18.4 Strategic Initiatives
    • 8.3.19 OraSure Technologies Inc
      • 8.3.19.1 Company Overview
      • 8.3.19.2 Financial Performance
      • 8.3.19.3 Product Benchmarking
      • 8.3.19.4 Strategic Initiatives
  • 8.4 List of Companies
Back to Top